Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5′nucleotidase (CD73) on endothelial cells  by Kas-Deelen, A.M. et al.
Cytomegalovirus infection increases the expression and activity of
ecto-ATPase (CD39) and ecto-5Pnucleotidase (CD73) on endothelial cells
A.M. Kas-Deelena, W.W. Bakkerb, P. Olingad, J. Visserd, E.F. de Maarc, W.J. van Sonc,
T.H. Thea, M.C. Harmsena;e;*
aDepartment of Clinical Immunology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
bDepartment of Pathology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
cDepartment of Nephrology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
dDepartment of Pharmacokinetics and Drug Delivery, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands
eDepartment of Medical Biology, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands
Received 27 October 2000; accepted 3 January 2001
First published online 6 February 2001
Edited by Hans-Dieter Klenk
Abstract We describe enhanced expression and enzymatic
activity of ecto-ATPase and ecto-5Pnucleotidase on CMV
infected endothelial cells as compared to uninfected cells. These
ectoenzymes play a major role in modulation of platelet
activation and aggregation. Furthermore, adenosine has a
modulatory effect upon inflammation. Addition of ATP, ADP
or AMP to cultures of CMV infected or uninfected endothelial
cells revealed increased turnover of AMP in CMV infected
endothelial cells. In addition, the superoxide production by
stimulated polymorphonuclear cells was inhibited in the presence
of CMV infected endothelial cells as compared to uninfected
cells, probably due to the enhanced activity of ecto-5Pnucleoti-
dase and associated to production of adenosine. ß 2001 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Human cytomegalovirus (CMV) infections in immunocom-
promised patients may cause CMV disease, which involves a
variety of organs and tissues [1]. The endothelial cell is one of
the cell types that becomes infected with CMV. This has con-
siderable impact on the physiological function of endothelial
cells. Particularly the coagulant properties of EC are a¡ected
by infection with CMV.
In the coagulation cascade ecto-ATPase (CD39) [2,3] and
ecto-5Pnucleotidase (CD73) have an important role in regula-
tion of platelet aggregation. During platelet activation, ATP
and ADP are released from the platelet dense granula. ADP is
essential for platelet recruitment and activation while ATP is
able to activate polymorphonuclear cells (PMN) to release
toxic oxygen products through stimulation of purinergic re-
ceptors present on these cells [4]. A rapid turnover of these
extracellular nucleotides (i.e. ATP and ADP) to AMP is able
to control both microthrombus formation as well as release of
oxygen radicals in the in£ammatory microenvironment. The
major degradation product of this enzyme activity, i.e. adeno-
sine, inhibits platelet activation [5]. Moreover, adenosine scav-
enges oxygen radicals and acts as a vasodilator in microvas-
cular beds [6].
Most herpesviruses [7], including CMV [8], induce enhanced
procoagulant activity at the surface of endothelial cells. An
increased expression of ecto-5Pnucleotidase at the same cell
surface could contribute to the delicate balance of hemostasis.
We hypothesize that CMV infection of endothelial cells up-
regulates the expression levels of ecto-ATPase and ecto-5Pnu-
cleotidase to counteract procoagulant activity induced by
CMV infection.
Furthermore, adenosine has a modulatory role in the in-
£ammatory response [4]. Hence, an increased production of
adenosine may moderate the severity of the in£ammatory re-
action and thus the immune response against the virus.
The present study was designed to evaluate alterations of
expression or activity of ecto-ATPase and ecto-5Pnucleotidase
upon endothelial cells after CMV infection in vitro. More-
over, coculture experiments were conducted to evaluate the
activity of in£ammatory cells in vitro following contact with
either CMV infected or uninfected endothelial cells.
2. Materials and methods
2.1. Cell culture
Human umbilical vein endothelial cells (HUVEC) were isolated
from human umbilical cord veins [9,10] and grown in endothelial
cell growth medium (RPMI 1640 supplemented with 20% fetal calf
serum, 50 Wg/ml endothelial cell growth factor, 5 U/ml heparin, 2 mM
L-glutamine, 100 U/ml penicillin and 100 Wg/ml streptomycin) using
culture £asks precoated with 1% gelatin. HUVEC were used at pas-
sages 1^3.
2.2. Virus
The endotheliotropic CMV clinical isolate TB42 [11] was used to
infect endothelial cell cultures. Viral infection of EC was achieved by
seeding trypsinized CMV infected EC together with uninfected EC at
a ratio 1:10 in culture £asks. After 5 days more than 80% of the EC
were infected. The percentage of infection was determined by indirect
immuno£uorescent staining with monoclonal antibody E13 (Seralab,
Sussex, UK) directed against CMV immediate early antigens.
2.3. Immunostaining and histochemistry
Immunostaining and enzyme histochemistry were performed to
demonstrate the presence of ecto-ATPase and ecto-5Pnucleotidase.
All stainings were performed upon monolayers of CMV infected
and uninfected HUVEC grown on Cookeslides. Immunostaining of
ecto-5Pnucleotidase was performed with a rabbit polyclonal IgG
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against human ecto-5Pnucleotidase (prepared according to standard
methods). Subsequently, cells were incubated with peroxidase-conju-
gated goat anti-rabbit antibodies. 3-amino, 9-ethylcarbazole (AEC)
(Sigma Chemical Co, St. Louis, MO, USA) was used to visualize
the reaction product. Ecto-ATPase was detected with a mouse mono-
clonal antibody against apyrase [12], followed by in order peroxidase-
conjugated goat anti-mouse antibodies and AEC.
Enzyme histochemistry to detect ecto-5Pnucleotidase (CD73) activ-
ity was carried out according to Wachstein and Meisel [13], using lead
as a capture ion. Brie£y, cells were ¢xed in acetone and incubated
with 1.0 mg/ml AMP in 0.08 M Tris^maleate bu¡er in the presence of
0.12% PbNO3 for 45 min at 37‡C. Lead was visualized by staining
with 2% NaSO3 for 30 s, yielding a brown precipitate. Detection of
ecto-ATPase (CD39) was performed using the cerium based method
as described previously [14,15]. Incubation was done with 1.5 mg/ml
ATP, 5 mM Mg(NO3)2 and 0.6 mM CeCl2 for 45 min at 37‡C. The
reaction product (cerium phosphate) was visualized by 0.05% H2O2
and 0.5 mg/ml 3P,3P-di-amino-benzidine in 0.1 M Tris bu¡er (pH 7.6)
resulting in a brown precipitate. In some experiments, the histochem-
ical reaction was followed by staining with monoclonal antibody E13
(Seralab, Sussex, UK). Indirect detection of E13 was done with alka-
line phosphatase-coupled goat anti-mouse antibodies and Fast Blue
(Sigma Chemical Co, St. Louis, MO, USA) as substrate.
2.4. Cytochrome c test
To determine the e¡ect of CMV infected endothelial cells on acti-
vation of polymorphonuclear granulocytes (PMN) we used the ferri-
cytochrome c reduction assay according to Pick and Mizel with minor
modi¢cations [16,17]. The superoxide anion production of PMN
stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP)
was measured in the presence or absence of either CMV infected or
uninfected HUVEC as well as in the presence of conditioned medium
from CMV infected or uninfected HUVEC. Medium was harvested
after 48 h. The assay was performed in 96-well microtiter plates con-
taining monolayers of CMV infected or uninfected endothelial cells or
with culture medium without cells. PMN were isolated from heparin-
ized blood samples obtained from healthy individuals by centrifuga-
tion on a Lymfoprep1 (Nycomed Pharma AS, Oslo, Norway,
d = 1.077 g/cm2) density gradient. Contaminating erythrocytes were
lysed with ice-cold ammoniumchloride (155 mM NH4Cl, 10 mM
KHCO3, 0.1 mM Na2EDTAW2H2O). After two washes with ice-cold
Hanks’ balanced salt solution (HBSS) without calcium and magnesi-
um, cells were adjusted to 106/ml in HBSS with calcium and magne-
sium and the temperature was adjusted to 37‡C. PMN were pre-
treated with 1 Wg/ml cytochalasin B (Serva, Heidelberg, Germany)
for 5 min, followed by activation with 2 ng/ml TNF-K for 15 min.
Endothelial cells were washed with HBSS, 0.2% BSA. Cocultures were
carried out by incubation of 2U105 PMN with approximately 2U104
HUVEC in HBSS containing 0.850 mg/ml cytochrome c (ferricyto-
chrome c : type VI from horse heart, Sigma Chemical Co, St. Louis,
MO, USA), with or without 59 U/ml superoxide dismutase (SOD)
(Sigma Chemical Co, St. Louis, MO, USA), and with or without
2U1037M fMLP (Sigma Chemical Co, St. Louis, MO, USA). All
reactions were performed in quadruple. The optical density (OD) at
550 nm was scanned in an automated microplate reader (Thermomax,
Molecular Devices, USA) at 5, 15, 30, 45, 60 and 90 min. Between
measurements plates were kept at 37‡C. The superoxide anion pro-
duction is expressed as the di¡erence in OD (vOD550 nm) between
values obtained in the presence of SOD versus OD values obtained
without SOD. The results are expressed as mean di¡erences measured
after various incubation times.
2.5. Release of adenine nucleotides of HUVEC after infection with
CMV
Con£uent monolayers of CMV infected and uninfected HUVEC
were grown in 6-well tissue culture plates. The cells were washed
with serum-free medium (RPMI supplemented with 0.2 mg/ml bovine
serum albumin) followed by incubation with serum-free medium con-
taining 250 WM MgCl2 and either 250 WM ATP (Boehringer, Mann-
heim, Germany), ADP (Sigma Chemical Co, St. Louis, MO, USA) or
AMP (Serva, Heidelberg, Germany). Supernatant samples were ana-
lyzed for ATP, ADP, AMP and adenosine contents by gradient ion
pair reversed-phase high performance liquid chromatography (HPLC)
using a Nova-Pak C18 column as described by Olinga et al. [18]. The
adenine nucleotide concentrations were corrected for di¡erences in cell
numbers per well.
3. Results
3.1. Immunostaining and histochemistry
CMV infected endothelial cells expressed markedly in-
creased levels of ecto-5Pnucleotidase (CD73) compared to un-
infected endothelial cells (Fig. 1C,G).
The infected cells showed a pattern of perinuclear cytoplas-
mic expression in combination with enhanced membrane ex-
pression. In particular, the endothelial cells which were not
fully cytomegalic yet, showed increased staining of ecto-5Pnu-
cleotidase. Furthermore, using enzyme histochemistry the en-
zymatic activity of ecto-5Pnucleotidase was also shown to be
increased (Fig. 1D,H). In contrast, No signi¢cant di¡erences
of ecto-5Pnucleotidase activity could be detected in cells with
high versus low CMV IE staining. As can be seen from Fig.
1A,E membrane expression as well as enzyme activity (Fig.
1B,F) of ecto-ATPase were increased in CMV infected cells
(Fig. 1A,B) as compared to uninfected cells (Fig. 1E,F). En-
Fig. 1. Expression and enzyme activity of ecto-ATPase (A, B, E, F) and ecto-5Pnucleotidase (C, D, G, H) on CMV infected endothelial cells
(A^D) and uninfected endothelial cells (E^H). Deposition of reaction product re£ecting ecto-ATPase and ecto-5Pnucleotidase activity is shown
in A, E, C, G. Enzyme activity is shown in B, F, D, H. CMV infected endothelial cells as depicted in B, D are stained with MoAb E13 di-
rected against CMV immediate early antigens (dark blue nuclear staining).
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dothelial cells showing enzyme staining for ATP were over
85% positive for CMV IE proteins (Fig. 1B).
3.2. Conversion of supplemented nucleotides to CMV infected
HUVEC
Addition of ATP to infected and uninfected cell cultures
resulted in higher extracellular ADP levels in supernatants
of CMV infected cultures as compared to uninfected endothe-
lial cells, whereas no di¡erences were observed in the ¢nal
concentration of ATP, AMP or adenosine in CMV infected
versus uninfected cells. Addition of ADP did not result in
di¡erent concentrations of ADP, AMP and adenosine be-
tween CMV infected or uninfected endothelial cells after a
1 h incubation period. In contrast, addition of AMP resulted
in signi¢cantly lower levels of extracellular AMP in the wells
with infected cells (P6 0.001) (Fig. 2).
3.3. Anti-in£ammatory e¡ect of CMV infected HUVEC upon
PMN in vitro
Coculture of monolayers of CMV infected endothelial cells
and PMN inhibited the oxygen radical production by PMN
after stimulation with fMLP (P6 0.001), whereas monolayers
of uninfected EC did not inhibit the oxygen radical produc-
tion. The incubation of PMN with endothelial cells without
fMLP had no stimulatory e¡ects on oxygen radical produc-
tion (Fig. 3). Incubation of PMN stimulated with fMLP and
conditioned medium derived from CMV infected or unin-
fected endothelial cells did not alter the production of oxygen
radicals (data not shown).
4. Discussion
In the present study we describe that CMV infection in-
duced the increased expression and activity of ecto-ATPase
(CD39) and ecto-5Pnucleotidase (CD73) in endothelial cells.
These enzymes are involved in the extracellular adenine nu-
cleotide metabolism. The increased expression of functional
ecto-5Pnucleotidase after CMV infection was demonstrated
in supernatants of infected cells by the higher turnover of
exogenously added AMP. However, we were unable to dem-
onstrate the increased activity of ecto-ATPase by di¡erences
in extracellular nucleotide levels. Stimulated PMN produced
lower amounts of oxygen radicals in the presence of CMV
infected endothelial cells than with uninfected endothelial
cells. The amount of oxygen radical production by PMN
was not in£uenced by the presence of conditioned medium
containing a lot of viral particles and multiple other CMV
induced factors, indicating the requirement of a cell surface
associated enzyme such as ecto-5Pnucleotidase. It would seem
likely that CD73 catalyzes the formation of adenosine from
AMP, upon which oxygen radicals are scavenged by adeno-
sine.
The metabolism of extracellular nucleotides is an important
regulatory tool to maintain a coagulant state as well as a
homeostasis of platelet aggregation. Three main anti-aggrega-
tory systems are involved in the control of platelet reactivity:
prostaglandin production, nitric oxide and ecto-nucleotidase
activity, respectively. The role of ecto-nucleotidases in platelet
aggregation is known for many years [19], and is well studied
in rat models [14]. Recently, the importance of ecto-ATPase
was con¢rmed in CD39-de¢cient mice, which had prolonged
Fig. 2. Addition of ATP, ADP or AMP to monolayers of CMV in-
fected or uninfected endothelial cells. 250 WM of ATP (A), ADP (B)
or AMP (C) was added for 1 h to monolayers of CMV infected
(hatched bars) and uninfected endothelial cells (white bars). The
supernatant was harvested and adenine nucleotide content was ana-
lyzed by HPLC. Data represent extracellular adenosine (ADO),
AMP, ADP, ATP concentration per cell per total added. The
mean þ S.D. of eight experiments are presented.
Fig. 3. Activity of fMLP stimulated PMN in the presence of CMV
infected or uninfected endothelial cells. Superoxide production of
PMN is shown in the absence (E) or presence of CMV infected en-
dothelial cells (*) or uninfected endothelial cells (F). Data represent
mean þ S.E.M. of four independent experiments performed in quad-
ruple.
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bleeding times and platelet hypofunction [20]. Under resting
conditions, the e⁄cient turnover of ATP and ADP to AMP
prevents onset of an ampli¢cation cascade of platelet recruit-
ment and activation induced by ADP and thus the formation
of a hemostatic plug. Moreover, ecto-5Pnucleotidase may en-
hance the role of ecto-ATPase by converting AMP to adeno-
sine, a known inhibitor of platelet aggregation. After contact
with an in£ammatory plasma factor as shown in the renal
perfusion model ex vivo, the expression and activity of ecto-
ATPase is severely reduced [12]. The reduction of ecto-ATP-
ase expression during in£ammation is due to the sensitivity of
this exoenzyme for oxygen radicals, and was observed in rats
[21] as well as in activated human endothelial cells [22]. The
expression of ecto-5Pnucleotidase is in£uenced by ischemic
conditions, re£ected by upregulation of this enzyme [6]. In
vivo, the pattern induced by hypoxia, i.e. a decreased ecto-
ATPase expression in combination with increased ecto-5Pnu-
cleotidase expression was for instance observed in biopsies of
kidney transplant recipients with chronic graft failure [23]. A
delayed onset of graft function after transplantation resulted
in a decreased expression of ecto-ATPase as well [24]. Obvi-
ously, these patients had su¡ered from considerable reperfu-
sion damage with release of oxygen radicals.
We describe the enhanced expression of ecto-ATPase and
ecto-5Pnucleotidase on CMV infected endothelial cells. Obvi-
ously, these molecules are not induced by activation of the
endothelial cells by proin£ammatory cytokines such as TNF-
K ; otherwise ecto-ATPase would probably be downregulated
[25]. It seems more likely that CMV infection of the cells
interferes with the endogenous expression of ecto-ATPase
and ecto-5Pnucleotidase. Whether this is a host defense reac-
tion of the endothelial cell to procoagulant e¡ects induced by
CMV infection or a regulatory e¡ect of CMV in the expres-
sion pathway of these molecules in the endothelial cell is cur-
rently unknown.
As a consequence of the upregulation of ecto-ATPase and
ecto-5Pnucleotidase, the production of adenosine is probably
enhanced. Both neutrophils as well as shear forces can en-
hance the production of adenosine by endothelial cells [6].
We did not measure the adenosine concentration in the cyto-
chrome c reduction assay, but the inhibitory e¡ect on the
radical production by PMN is presumably due to the in-
creased production of adenosine. In the experiments with ex-
ternal added nucleotides, adenosine did not accumulate in the
supernatant of infected endothelial cells. Whereas ATP, ADP
and AMP are relatively stable in the extracellular milieu, ad-
enosine is rapidly taken up inside cells ; it is processed to
inosine and hypoxanthine or it can bind to purine receptors
[26,27]. Therefore to maintain the anti-aggregatory and anti-
in£ammatory e¡ects of adenosine in vitro a constant rate of
production is required.
In the immediate microenvironment of adenosine produc-
tion, the increased adenosine levels may a¡ect several mecha-
nisms. Adenosine has an anti-aggregatory in£uence on platelet
reactivity. Whereas most herpesviruses [7], including CMV [8],
induce an enhanced procoagulant environment at the surface
of endothelial cells, the increased expression of ecto-5Pnucleo-
tidase at the same cell surface, as observed during CMV in-
fection, may restore the delicate balance of hemostasis.
Furthermore, adenosine has a modulatory role in the in-
£ammatory response. Binding of ATP to purine receptors
on the PMN has a proin£ammatory e¡ect. It increases the
PMN adherence and production of oxygen radicals. However,
adenosine has potent anti-in£ammatory capacities and causes
inhibition of PMN transmigration and activation [4]. Thus, an
increased production of adenosine may modulate the severity
of the in£ammatory reaction and thus the immune response
against the virus.
In addition, a higher availability of adenosine locally at the
endothelial cell surface may enhance the barrier function of
endothelial cells. Proin£ammatory cytokines increase the per-
meability of the endothelial layer. The binding of adenosine to
A2B type purine receptors of endothelial cells triggers an in-
tracellular signal, which can restore the increased permeability
of endothelial cells [28]. After infection with cytomegalovirus
the endothelial cells develop a cytomegalic morphology and
can detach from the basal membrane. CMV patients occasion-
ally have cytomegalic endothelial cells in the blood stream
[29]. Possibly, the increased production of adenosine contrib-
utes to the restoration of the integrity of the endothelial layer.
Whether this a¡ects the lesions induced by detachment of
CMV infected endothelial cells remains to be investigated.
In conclusion, the increased expression of ecto-5Pnucleoti-
dase and ecto-ATPase at CMV infected endothelial cells may
serve as a novel viral evasion strategy, a¡ecting the regulation
of coagulation, in£ammation and integrity of the endothelial
layer.
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